((R)-4,4-DIMETHYLPYRROLIDIN-2-YL)METHANOL, 95.0%, 1g

3-Benzyl-5-(trifluoromethyl)-3-azabicyclo[3.1.0]hexane-1-carboxylic acid, 5g

(2R,4R)-Methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride, 95.0%, 10g

ISOPROPYL ((PERFLUOROPHENOXY)(PHENOXY)PHOSPHORYL)-L-ALANINATE, 95%, 10g

6-BROMO-2,3-DIMETHYL-2H-INDAZOLE, 95.0%, 1g

5-Chloromethyl-3-phenyl-[1,2,4]oxadiazole, 97.0%, 1g

Magnesium foil 99.8% 0.1 x 100 x 100 mm 1 pc

Ethyl 4-bromobut-2-enoate, 84.0%, 10g

2-Amino-3-methyl-5-nitropyridine>98.0%(GC)(T)1g

4-(chloromethyl)-2-(4-fluorophenyl)-1,3-oxazole, 95.0%, 250mg

1-(Phenylsulfonyl)pyrrole, 98.0%, 1g

4-Chlorophenyl hydrazine, 95.0%, 25g

(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)but-2-enamide (Dacomitinib Impurity), 98%, 50mg